ALVEOFACT

This brand name is authorized in Austria, Croatia, Lithuania, Turkey.

Active ingredients

The drug ALVEOFACT contains one active pharmaceutical ingredient (API):

1
UNII S866O45PIG - BERACTANT
 
Read more about Beractant

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R07AA02 Natural phospholipids R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AA Lung surfactants
Discover more medicines within R07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HR Agencija za lijekove i medicinske proizvode HR-H-384673340
LT Valstybinė vaistų kontrolės tarnyba 1070285, 1073525
TR İlaç ve Tıbbi Cihaz Kurumu 8699702779004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈